micro particles contamination: innocent bystander or real threat ?
Embed Size (px)
DESCRIPTION
IFAD Antwerpen 2012. Micro Particles Contamination: Innocent Bystander or Real Threat ?. Thomas Jack; MD Dept. of Pediatric Cardiology and Intensive Care Medicine. Pediatric and Adolescent Medicine Dept. of Pediatric Cardiology and Intensive Care Medicine Prof. Dr. med. A. Wessel. - PowerPoint PPT PresentationTRANSCRIPT

Micro Particles Contamination: Innocent Bystander or Real
Threat ?
Pediatric and Adolescent MedicineDept. of Pediatric Cardiology and Intensive Care MedicineProf. Dr. med. A. Wessel
Thomas Jack; MDDept. of Pediatric Cardiology and Intensive Care Medicine
IFAD Antwerpen 2012

Disclosure
Pall Corporation
B. Braun Melsungen AG
Pediatric and Adolescent MedicineDept. of Pediatric Cardiology and Intensive Care MedicineProf. Dr. med. A. Wessel

Background: Particles and intravenous therapy
• Particulate contamination during intravenous therapy has been described for many years [1].
• In an intensive care setting it has been estimated that up to one million particles per patient per day may be infused [2]
Different effects are proven [3,4,5]:• Embolisation• Thrombogenic effects• Immunomodulation• Impairment of microcirculation
[1] Garvan JM & Gunner BW. The harmful effects of particles in intravenous fluids. Med. J. Austr. 1964. 41 (2):1-6. [2] Mehrkens HH. Klin Anasthesiol Intensivther. 1977 (14):106-13.[3] Walpot H. Anaesthesist.1989 Nov;38(11):617-21.[4] Puntis JW. Arch Dis Child. 1992 Dec;67(12):1475-7.[5] Lehr HA. Am J Respir Crit Care Med. 2002 Feb 15;165(4):514-20.
Pediatric and Adolescent MedicineDept. of Pediatric Cardiology and Intensive Care MedicineProf. Dr. med. A. Wessel

Origin of particles
1. Drug incompatibility reactions– Account for 20% of all medication errors and up to 90% of
administration errors – Impair efficacy of administered drugs or increase risk of
side effects, even formation of toxic compounds– on ICU, coinfusion of two drugs is uncertain in up to 45%
of instances in which the compatibility of drug combination is unknown
Taxis K, Barber N. Eur J Clin Pharmacol. 2004; 59: 815 – 7Vogel Kahmann I. et al. Anaesthesist. 2003 52: 409 – 412Kähny-Simonius J. Schweiz Rundsch Med Prax. 1993; 82:1320-7
Pediatric and Adolescent MedicineDept. of Pediatric Cardiology and Intensive Care MedicinePD Dr. med. H. Bertram

Origin of particles2. Incomplete reconstitution of drugs or particles
inherent to drug formulation
– Generic formulations of antibiotics have been found to be heavily contaminated with particles
– Parenteral nutrition admixtures: enlarged lipid droplets arise from emulsion instability and calcium phosphate precipitates occur
3. Arise from components of the infusion system (e.g. three way taps, roller pumps a.o.)Sendo T. et al. J Clin Pharmacy and Therapeutics. 2001; 26: 87 – 91 Driscoll DF et al. Clinical Nutrition. 2005; 24: 699-700Lehr H.-A. et al. Am J Respir Crit Care Med. 2002; 165: 514–520 Driscoll DF et al Clinical Nutrition. 2006; 25(5): 842-50
Pediatric and Adolescent MedicineDept. of Pediatric Cardiology and Intensive Care MedicinePD Dr. med. H. Bertram

Origin of particlesAggravating factors for particle formation
• Quantity of administered drugs and complexity of infusion regimen [1,2]
• Lack of available intravenous lines [3]• Lack of incompatibility information for administered drugs
or their formulation [3]
[1] Jack & Brent et al. Intensive Care Med (2010) 36:707–711
[2] Mehrkens HH. Klin Anasthesiol Intensivther. 1977 (14):106-13.[3] Schroder F. Infusionsther Transfusionsmed 1994; 21: 52-58
Pediatric and Adolescent MedicineDept. of Pediatric Cardiology and Intensive Care MedicinePD Dr. med. H. Bertram

Electron microscopy of used in-line filters
• 20 Filters of different patients were examined after 72 hours use on our PICU
• Average number of particles found on the surface of the membrane was 542/cm2.
• More than 20% of the examined filters showed signs of beginning blockage by particles retaintion
Jack and Brent et al.; Intensive Care Med. (2010)

Electrone microscopy
Particles from a filter membrane after 72 hours use in a 17 yaer old girl after aortic valve replacemant.[1] In-line filtration prevents intravascular infusion of "knife blades" and
"spearheads" after open heart surgery. Brent B, Jack T, Sasse M; Eur Heart J. 2007 May; 28(10)
70%of the demonstarted particles were larger than a pulmonary capillary

Particulate contamination retained on filter membranes Precipitation leads to blockage
Parenteral nutrition with high osmolarity, 5ml/h, analysis of filter membrane after 72 hours in use

Pediatric and Adolescent MedicineDept. of Pediatric Cardiology and Intensive Care MedicineProf. Dr. med. A. Wessel
Particulate contamination retained on filter membranes Dependence on complexity of infusion regimen
applied components via filter membrane
part
icle
load
/ cm
2
Jack and Brent et al.; Intensive Care Med. (2010)

Clinical Data about the influence of intravenous particles
➢ Deleterious effects of particles on microperfusion in different organ systems after ischemia and reperfusion (Lehr et al. 2002 and 2008; Walpot et al. 1989)
➢ Reduction of thrombophlebitis after elimination of particles with infusion filters (Falchuk et al. 1985; Chee und Tan 2002)
➢ Increase of typical neonatal complications like inflammation, sepsis and enterocolitis (van Lingen et al. 2004)
➢ Chee S& Tan W (2002: Reducing Infusion Phlebitis in Singapore Hospitals Using Extended Life End-Line Filters. Journal of Infusion Nursing Vol 25, No 2:95-104.
➢ Falchuk KH, Peterson l, McNeil BJ (1985): Microparticulate-induces Phlebitis. Ist prevention by in-line filtration. NEJM, Jan 10; 312(2):78-82
➢ Van Lingen RA, Baerts W, Marquering ACM, Ruijs GJHM (2004): The use of in-line filtration in sick newborn infants. Acta paedirtica 93; 1-5 ➢ Lehr HA, Br unner J, Rangoonwala R, Kirkpatrick CJ (2002) Particulate Matter Contamination of Intravenous Antibiotics Aggravates Loss
of Functional Capillary Density in Postischemic Striated Muscle. Am. J. Resp. Crit. Care Med Volume 165. Number 4. February: 514-520.➢ Walpot H, Franke RP, Burchard WG, Agternkamp, Mueller FG, Mittermayer Ch, Kalff G (1989) Particulate contamination of infusion
solutions and drug additives during long-trem intensiv care (Part 2-Animal model). Anaesthesist 38: 617-621.

van Lingen RA, Baerts W, Marquering ACM, Ruijs GJHM: The use of in-line intravenous filters in sick newborn infants. Acta Paediatr. 2004 93; 1-5.
The use of in-line intravenous filters in sick newborn infants

Prospective, randomized clinical trial for the use of In-line filtration in critically ill childrenStudy design
• Prior to the study: Optimization of infusion regimen to prevent precipitation and incompatibilities of drugs and solutions
• Randomization of pediatric intensive care patients to either control or interventional group
• Interventional group receiving in-line infusion filters throughout complete infusion therapy (all solutions and medications), open label
• Primary endpoints: Reduction in incidence of severe defined complications (SIRS, sepsis organ failure, mortality and thrombosis), study was powered (80%) for a reduction in the overall complication ratePediatric and Adolescent
MedicineDept. of Pediatric Cardiology and Intensive Care MedicineProf. Dr. med. A. Wessel

optio
nal
catech. 1following/change
catech. 2
catech. 3
following/change
following/change
AA CH Lipidoptional
syringe pumpoptional
syringe pump
CVP measurement
basic iv-solution
short infusion
bolus application
volumereplacement
optio
nal
Central venous catheter (3 lumen) for parenteral nutrition and catecholamine therapy
sedation
heparinization
Heparin
Propofol
jugulas veinright / left
subclavian veinright / left
femoral veinright / left
Clonidin
Midazolam
Fentanyl
Comprehensive view – Infusion setup Hannover Medical School
Pediatric and Adolescent MedicineDept. of Pediatric Cardiology and Intensive Care MedicineProf. Dr. med. A. Wessel

Prospective, randomized clinical trial for the use of In-line filtration in critically ill children
Pediatric and Adolescent MedicineDept. of Pediatric Cardiology and Intensive Care MedicineProf. Dr. med. A. Wessel
• Gaussian distribution of patients to both groups (406 non-filter vs. 401 filter)
• No differences in PIM II score, median age, weight or gender distribution
• Heterogeneous background of disease with no significant differences in filter vs. control group

Primary outcome: Complication ratio and Mortality: Filter vs non-Filter group (n= 807)p=0,003
p=0,093
Jack T & Boehne M, et al. Intensive Care Med (2012) 38:1008–1016

Significant reduction in incidence of SIRS in the filter group (123 non-filter group vs. 90 filter group; 95% CI, p<0.01)
Pediatric and Adolescent MedicineDept. of Pediatric Cardiology and Intensive Care MedicinePD Dr. med. H. Bertram
Jack T & Boehne M, et al. Intensive Care Med (2012) 38:1008–1016

Results: Hazard Ratios of primary Endpoints and Mortality
Jack T & Boehne M, et al. Intensive Care Med (2012) 38:1008–1016

P=0,028
Length of stay on PICU
Length of mechanical j ventilation jjjj
Min
utes
Jack T & Boehne M, et al. Intensive Care Med (2012) 38:1008–1016

* *
* * P<0,05
Organ dysfunctions (IPSCC 2005):
non-Filter
Filter
Boehne M & Jack T, et al. unpublished data, under review

Summary• Particulate contamination of infusion solutions are not a
threat, but represent an additional risk for intensive care patients
• Particles seem to influence immune reaction
• SIRS, Length of stay and length of MV was significantly reduced in the interventional group by the use of in-line filtration
• Therefore ifiltration offers a new therapeutic option to reduce complications on ICU
• Ongoing analyses focus on subgroups and economic aspects of filter use
Pediatric and Adolescent MedicineDept. of Pediatric Cardiology and Intensive Care MedicineProf. Dr. med. A. Wessel

Thank you for your attention
Pediatric and Adolescent MedicineDept. of Pediatric Cardiology and Intensive Care MedicineProf. Dr. med. A. Wessel
Members of the study groupMartin Boehne MDBernadette Brent MDMichael Sasse MDJohann WesselsMichaela AburaVerena QuartierMarkus BeckerDilek YilmazMeike Müller PhDKatharina Seewald PhDArmin Braun PhDArmin Wessel MD, PhD